Page last updated: 2024-09-04

glucagon and acipimox

glucagon has been researched along with acipimox in 13 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(acipimox)
Trials
(acipimox)
Recent Studies (post-2010) (acipimox)
26,0391,4983,05428314050

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (76.92)18.2507
2000's3 (23.08)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti, KG; Catalano, C; Farrer, M; Fulcher, GR; Walker, M1
Cathelineau, G; Gautier, JF; Jandrain, B; Lacroix, M; Lefèbvre, PJ; Mosora, F; Pirnay, F; Scheen, AJ1
Puhakainen, I; Yki-Järvinen, H1
Groop, L; Härkönen, M; Melander, A; Saloranta, C; Taskinen, MR; Widen, E1
Alberti, KG; Berrish, TS; Cooper, BG; Elliott, C; Orskov, H; Reed, JW; Walker, M1
Alberti, KG; Farrer, M; Fulcher, GR; Johnson, AS; Walker, M1
Bolli, GB1
D'Onofrio, F; Gambardella, A; Giugliano, D; Gualdiero, P; Howard, BV; Paolisso, G; Rizzo, MR; Saccomanno, F; Tagliamonte, MR1
Marks, V; Morgan, L; Norris, F; Ranganath, L; Wright, J2
Bjerve, KS; Grill, VE; Mostad, IL; Qvigstad, E1
Christiansen, JS; Jørgensen, JO; Møller, N; Nielsen, S; Nørrelund, H1
Carey, PE; Cline, GW; Cobelli, C; Dalla Man, C; English, PT; Firbank, MJ; Gerrard, J; Taylor, R1

Trials

7 trial(s) available for glucagon and acipimox

ArticleYear
Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Clinical science (London, England : 1979), 1992, Volume: 82, Issue:5

    Topics: 3-Hydroxybutyric Acid; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Hydrocortisone; Hydroxybutyrates; Hypolipidemic Agents; Lipolysis; Male; Middle Aged; Norepinephrine; Pyrazines

1992
Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
    European journal of applied physiology and occupational physiology, 1994, Volume: 68, Issue:5

    Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Carbohydrate Metabolism; Energy Metabolism; Glucagon; Glucose; Glycerol; Humans; Hypolipidemic Agents; Insulin; Lipid Metabolism; Lipolysis; Male; Oxidation-Reduction; Physical Exertion; Pyrazines

1994
Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
    Diabetes, 1993, Volume: 42, Issue:12

    Topics: Analysis of Variance; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Growth Hormone; Humans; Hydrocortisone; Hypolipidemic Agents; Lactates; Lipolysis; Liver; Male; Middle Aged; Oxygen Consumption; Pyrazines; Tritium

1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
    Diabetes, 1993, Volume: 42, Issue:11

    Topics: Blood Glucose; Calorimetry; Chromatography, High Pressure Liquid; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hypolipidemic Agents; Insulin; Liver; Male; Middle Aged; Pyrazines; Time Factors

1993
The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 1993, Volume: 10, Issue:2

    Topics: 3-Hydroxybutyric Acid; Blood Glucose; C-Peptide; Calorimetry; Carbon Dioxide; Diabetes Mellitus, Type 2; Energy Metabolism; Exercise; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Hypolipidemic Agents; Insulin; Lactates; Male; Middle Aged; Nitrogen; Oxygen Consumption; Pyrazines; Reference Values

1993
Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Metabolism: clinical and experimental, 1993, Volume: 42, Issue:3

    Topics: Adult; Alanine; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Hypolipidemic Agents; Insulin; Lactates; Lipid Metabolism; Male; Oxidation-Reduction; Pyrazines; Pyruvates; Radioimmunoassay; Time Factors

1993
Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
    Diabetologia, 1998, Volume: 41, Issue:10

    Topics: Adult; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypolipidemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Oxygen Consumption; Placebos; Pyrazines

1998

Other Studies

6 other study(ies) available for glucagon and acipimox

ArticleYear
Importance of catecholamines in defense against insulin hypoglycemia in humans.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Heparin; Homeostasis; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypolipidemic Agents; Insulin; Lipolysis; Phentolamine; Propranolol; Pyrazines

1998
Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.
    Clinical science (London, England : 1979), 1999, Volume: 96, Issue:4

    Topics: Adult; Analysis of Variance; Area Under Curve; Case-Control Studies; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Heparin; Humans; Insulin; Models, Biological; Neurotransmitter Agents; Obesity; Peptide Fragments; Postprandial Period; Pyrazines; Triglycerides

1999
The effect of circulating non-esterified fatty acids on the entero-insular axis.
    European journal of clinical investigation, 1999, Volume: 29, Issue:1

    Topics: Adult; Blood Glucose; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Heparin; Humans; Insulin; Intestines; Islets of Langerhans; Obesity; Peptide Fragments; Protein Precursors; Pyrazines

1999
Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 284, Issue:1

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Proteins; Energy Intake; Exercise; Fasting; Fatty Acids; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Proinsulin; Pyrazines

2003
Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    European journal of endocrinology, 2004, Volume: 150, Issue:6

    Topics: Adult; Amino Acids; Blood Flow Velocity; Blood Glucose; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Forearm; Glucagon; Glucose Clamp Technique; Glycerol; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lactic Acid; Lipolysis; Male; Microdialysis; Plethysmography; Pyrazines; Somatostatin

2004
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    American journal of physiology. Endocrinology and metabolism, 2005, Volume: 289, Issue:6

    Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glucose; Glycerol; Humans; Hypolipidemic Agents; Insulin; Kinetics; Lipolysis; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxidation-Reduction; Placebos; Pyrazines; Triglycerides

2005